News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
342 Results
Type
Article (15)
Press Release (327)
Section
Business (77)
Deals (12)
Drug Development (92)
FDA (13)
Job Trends (41)
News (172)
Policy (17)
Tag
Alliances (15)
Approvals (12)
ASCO (3)
Best Places to Work (40)
Brain cancer (3)
Cancer (12)
Clinical research (76)
Collaboration (1)
COVID-19 (5)
Data (22)
Diagnostics (5)
Earnings (36)
Events (83)
FDA (14)
Funding (1)
Government (6)
Healthcare (6)
Hematology (2)
Infectious disease (5)
Intellectual property (3)
IPO (11)
Job creations (1)
Liver cancer (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2026 (6)
Non-profit (1)
Pancreatic cancer (5)
Patents (6)
Patient recruitment (3)
People (16)
Phase 1 (50)
Phase 2 (43)
Phase 3 (23)
Pipeline (18)
Preclinical (20)
Real estate (1)
Regulatory (16)
Research institute (4)
Startups (1)
Vaccines (2)
Date
Last 30 days (2)
Last 365 days (41)
2026 (28)
2025 (33)
2024 (23)
2023 (34)
2022 (42)
2021 (31)
2020 (71)
2019 (33)
2018 (10)
2017 (22)
2016 (14)
2013 (1)
Location
Asia (2)
Canada (1)
Europe (3)
Japan (1)
Texas (62)
United States (62)
342 Results for "moleculin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
July 31, 2026
·
12 min read
Press Releases
Moleculin Announces Pricing of $9.3 Million Public Offering
August 2, 2026
·
5 min read
Press Releases
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
August 27, 2026
·
5 min read
Press Releases
Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial
August 14, 2026
·
11 min read
Press Releases
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
April 23, 2026
·
7 min read
Press Releases
Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor “What This Means” Segment
July 6, 2026
·
4 min read
Press Releases
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
May 8, 2026
·
5 min read
Press Releases
Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin’s Annamycin in Relapsed/Refractory AML
June 5, 2026
·
8 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
·
9 min read
Press Releases
Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
June 4, 2026
·
4 min read
1 of 35
Next
